World Patient Safety Summit is Sold Out But Space is Available at the Breakout Sessions, Held the Day after the World Summit, at the Royal Society in London
The latest advances in vaccine safety, reducing unnecessary C-sections and person & patient engagement will be among the varied breakout sessions offered the day after the 6th Annual World Patient Safety, Science & Technology Summit in London by the Patient Safety Movement Foundation. The breakout sessions will convene on Sunday, February 25, 2018 at the prestigious Royal Society, the independent scientific academy of the United Kingdom and the Commonwealth, dedicated to promoting excellence in science.
This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20180219005119/en/
Limited Space available to participate with experts at the 6th Annual World Patient Safety, Science & Technology Summit Break Out Sessions at the Royal Society in London (Photo: Business Wire)
The breakout sessions are full-day working meetings structured for shared learning on existing Actionable Patient Safety Solutions (APSS) – collaborative, evidence-based processes that show results in patient safety – and for developing new APSS. These sessions provide healthcare professionals, advocates, and enthusiasts the opportunity to contribute their experiences and expertise, which is critical to process improvement, while also promoting transparency and encouraging aligned incentives that will eventually lead to ZERO preventable patient deaths in hospitals by 2020.
The World Patient Safety, Science & Technology Summit, and Breakout Sessions are supported by the Rt. Hon Jeremy Hunt, MP, Secretary of State for Health and Social Care, Department of Health United Kingdom and co-convened by the European Society of Anaesthesiology. This year’s breakout sessions will include:
Many healthcare institutions can improve patient safety through procedures related to immunization, safety monitoring, and pertinent participatory information systems. This session will exchange the latest advances in patient and vaccine safety research methods, and pertinent key performance indicators for healthcare institutions. Finally, the group will crystallize the plans for developing an Actionable Patient Safety Solutions (APSS) that focuses on safeguarding patients through engagement, protecting the providers caring for patients, and shielding at-risk patients. Other key topics of discussion will include systematic monitoring of adverse events and feedback knowledge updates for healthcare providers.
Person and Family Engagement (PFE)
Person and Family Engagement is an underused “natural resource” for improving patient safety. Ample evidence has accumulated which demonstrates that when patients are actively engaged partners, they achieve better outcomes and help produce innovative solutions. Persons who use care or manage its use for loved ones are highly motivated to partner with professional and organizational care providers to drive change across the care continuum. Their experiences bring an urgency to the patient safety movement that propels action by generating empathy – they engage our hearts as well as our minds and hands.
Injuries related to falls impose a catastrophic cost of care on families and healthcare economics. Fall prevention and injury reduction require a collaborative approach involving leadership, clinical intervention, and patent and family partnership. This session will explore the Actionable Patient Safety Solutions for Fall Prevention and Injury Reduction. The latest research and science will be discussed along with revisions to the APSS that can assist in care that reduces harm, injury, and death.
Driving Sustainable Change in Hand Hygiene - The Problem We Only THINK We Solved
If hand hygiene is the most effective way to prevent avoidable HAIs, why is global compliance below 50%? Recent studies prove that three elements are essential for sustainable improvement: Accurate measurement, evidence-based feedback, and top-down accountability. The current hand hygiene APSS incorporates this learning into actionable guidelines. Attendees will learn how to translate emerging science into action by providing input into the APSS through sharing experience & knowledge.
Reducing Unnecessary C-Sections
One of the life-altering procedures of modern obstetrics is the performance of an appropriately timed and executed cesarean delivery and yet over performance can lead to short and long-term complications and maternal deaths. In parts of the world increased cesarean section rates are associated with rising maternal mortality rates. Therefore, the avoidance of performing unnecessary cesarean births has become an important long-term strategy in reducing maternal mortality.
Sepsis is a growing issue worldwide. This session will review and discuss the latest APSS #9A: Early Detection & Treatment of Sepsis for High-income Countries and the new APSS #9B: Early Detection & Treatment of Sepsis for Low and Middle-income Countries. Participants will share ideas and make suggestions to improve the APSS based on their knowledge and experience. The goal of the working group session is to facilitate revisions that increase APSS effectiveness and identify ways to disseminate APSSs more widely.
Should drug shortages be viewed as a patient safety issue? That is one of the issues the working group will tackle in this session. Pharmaceutical shortages have a profound effect on clinical practice and patient outcomes and increase health care costs. The objectives of the session are to understand the reasons for drug shortages and define alternatives for shortage prevention and mitigation. Participants will also discuss the role of technology in coming up with solutions.
For more information on the breakout sessions, or to register, please visit http://www.cvent.com/events/6th-annual-world-patient-safety-science-technology-summit/event-summary-354a3027b4904b42940fda0fc321463f.aspx.
About Patient Safety Movement Foundation:
More than 200,000 U.S. patients and three million worldwide die each year from preventable causes. The Patient Safety Movement Foundation (PSMF) was established through the support of the Masimo Foundation for Ethics, Innovation, and Competition in Healthcare to reduce that number of preventable deaths to zero by 2020 (0X2020). Improving patient safety requires a collaborative effort from all stakeholders, including patients, healthcare providers, medical technology companies, government, employers, and private payers. The PSMF works with all stakeholders to address problems with actionable solutions. The Foundation also convenes the World Patient Safety, Science and Technology Summit bringing together some of the world’s best minds for thought-provoking discussions and new ideas that challenge the status quo. By presenting specific, high-impact solutions to meet patient safety challenges, called Actionable Patient Safety Solutions, encouraging medical technology companies to share the data their products are purchased for, and asking hospitals to make commitments to implement Actionable Patient Safety Solutions, the Patient Safety Movement Foundation is working toward zero preventable deaths by 2020. Visit http://patientsafetymovement.org/.
Patient Safety Movement Foundation
Tanya Lyon, (949) 351-2858
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Tilaa tiedotteet sähköpostiisi
Haluatko tietää asioista ensimmäisten joukossa? Kun tilaat mediatiedotteemme, saat ne sähköpostiisi välittömästi julkaisuhetkellä. Tilauksen voit halutessasi perua milloin tahansa.
Lue lisää julkaisijalta Business Wire
American Airlines Announces Nonstop Philadelphia (PHL) to Orlando Melbourne (MLB)22.9.2018 01:13 | Tiedote
Glorious beaches by day and theme park fireworks by night just got more convenient for Philadelphia travelers. American Airlines announced today that it will begin nonstop flights to Orlando Melbourne International Airport (MLB) starting February 16, 2019. The Central Florida airport is conveniently located in the heart of the tourism region and is the closest airport to NASA rocket launches, Port Canaveral’s cruises and what critics call “some of the most beautiful beaches Florida has to offer.” The flights will depart Saturdays from Philadelphia at 8:05 a.m., arriving in Florida at 10:48 a.m. The Embraer 175 jet arrival time syncs perfectly with cruise ship noon early boarding. Melbourne Airport Express offers nonstop shuttle service to the port, and all major rental car companies are onsite. The return flight to PHL departs at 11:24 a.m. and arrives in PHL at 1:55 p.m., with enough time to connect to some of American’s largest international destinations, including recently announced
Amy Palladino Joins BCW as Executive Vice President, Managing Director, Corporate Practice21.9.2018 20:43 | Tiedote
BCW (Burson Cohn & Wolfe), a leading global communications agency, today announced that Amy Palladino has joined the agency as Executive Vice President, Managing Director in the agency’s U.S. Corporate Practice. Based in New York, Palladino will focus on senior client counsel and executive positioning for the agency’s largest corporate clients. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180921005507/en/ Amy Palladino Joins BCW (Burson Cohn & Wolfe) “Amy is a talented and highly experienced communications executive with a track record of solving clients’ complex challenges and building business through smart, integrated communications approaches,” said Chris Foster, President, North America, BCW. “Her creativity and judgement will be enormously valuable to our current and prospective clients.” Palladino has more than 20 years of experience advising global clients across numerous industries, including technology, healthcar
Heidelberg Engineering Announces the CE-Marking of ANTERION21.9.2018 19:41 | Tiedote
Heidelberg Engineering, the leader in diagnostic imaging known for the internationally-acclaimed SPECTRALIS ® retina and glaucoma platform, announces the CE-marking of ANTERION ® – an innovative platform designed to transform anterior segment diagnostics and workflow. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180921005442/en/ The new Heidelberg Engineering ANTERION® provides the most important anterior segment examinations and measurements in one modular, upgradeable platform. (Graphic: Business Wire) The new ANTERION provides the most important anterior segment examinations and measurements in one modular, upgradeable platform. It is a single, workflow-efficient solution that brings together corneal topography and tomography, anterior segment metrics, axial length measurement and IOL calculation to transform the day-to-day routine of busy practices and clinics. Heidelberg Engineering has leveraged its core OCT technolo
Florian Winterstein Becomes New CEO of Jedox21.9.2018 18:46 | Tiedote
The supervisory board of Jedox AG, a leading vendor of business intelligence and enterprise planning software, has appointed Florian Winterstein as Chief Executive Officer (CEO) effective October 2, 2018. This nomination will support Jedox’s international growth and a new development phase initiated by its latest fund raising in April 2018 with Iris Capital, eCAPITAL entrepreneurial Partners AG and Wecken & Cie. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180921005416/en/ Florian Winterstein (Photo: Business Wire) With 25 years of experience in strategy consulting and leadership in software and service organizations, Winterstein brings to the company a valuable combination of expertise in cloud solutions, business development, and value creation for customers and partners. As former Chief Strategy Officer of BravoSolution, he positioned the software-as-a-service company as trendsetting digitalization partner, extending it
Avinor to Test Autonomous Snowploughs at Oslo Airport This Winter21.9.2018 17:37 | Tiedote
Since 2010 Avinor has had a vision and a desire to automate winter maintenance. In March autonomous snow clearing was demonstrated at Fagernes Airport, and this winter Avinor is taking this a step further by testing two autonomous snowploughs at Oslo Airport. The project is one of the first globally where large machinery will operate autonomously to keep snow away from airport areas. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180921005363/en/ Avinor to Test Autonomous Snowploughs at Oslo Airport This Winter (Photo: Business Wire) “Innovation is important to Avinor. In the future, many tasks in aviation will be resolved in other ways than today. Avinor wants to test autonomy, and does of course see a potential for rationalization in the future through new solutions for winter operations and in other areas. Avinor is at the forefront of testing this technology, but it is essential that safety is ensured in all such testing
Takeda Receives Positive CHMP Opinion Recommending ALUNBRIG® (brigatinib) for the Treatment of ALK+ Non-Small Cell Lung Cancer in Patients Previously Treated with Crizotinib21.9.2018 16:30 | Tiedote
Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion, recommending the full approval of ALUNBRIG® (brigatinib) as a monotherapy for the treatment of adult patients with anaplastic lymphoma kinase-positive (ALK+) advanced non-small cell lung cancer (NSCLC) previously treated with crizotinib. ALUNBRIG is a tyrosine kinase inhibitor (TKI) designed to target and inhibit the ALK mutation in NSCLC. Approximately three to five percent of NSCLC patients globally have the ALK mutation. If the CHMP opinion is affirmed, and the European Commission approves ALUNBRIG, it will become the only ALK inhibitor available in the European Union as a one tablet per day dose that can be taken with or without food. The randomized, global Phase 2 ALTA trial was designed to investigate the efficacy and safety of ALUNBRIG in patients with locally advanced or metastatic ALK+
Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.Tutustu uutishuoneeseemme